跳至主要内容
临床试验/NCT07451132
NCT07451132已完成不适用

Effect of a Time-restricted Eating Protocol on Glucose Homeostasis, Markers of Circadian System, Appetite Control, and Oxidative Stress Parameters in Night Shift Workers

University of Chile1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2023年10月30日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Change from Baseline in the mean fasting glycemia at 8 weeks

研究概览

简要总结

The goal of this clinical trial is to learn about the effect of time-restricted eating (TRE) to 10 hours per day on glucose homeostasis, markers of the circadian system, homeostatic and hedonic regulation of appetite, and inflammation/oxidative stress status in night shift workers. The main questions it aims to answer are: 1) How does a time-restricted eating protocol affect glucose homeostasis in shift workers? and 2) How does a time-restricted eating protocol affect markers of the circadian system, homeostatic and hedonic regulation of appetite, and inflammation/oxidative stress status in shift workers? Participants will be asked to follow a TRE protocol on which they must restrict their eating to a self-selected time window of 10 hours a day, with mandatory fasting time between 24:00-06:00h. for 8 weeks. Researchers will compare the intervention with an additional period of 8 weeks, in which the participants will follow their usual diet without any time restriction, to see if the intervention improves glucose regulation appetite and markers of circadian system, homeostatic and hedonic regulation of appetite, and inflammation/oxidative stress.

详细描述

This is a randomized, crossover, controlled, within-subject study. After recruitment, participants will be randomized to one of two conditions: i) Time-restricted eating (TRE), with an eating window of 10 hours per day but without any other diet modification (e.g., types of food or amount of energy consumed). Each participant can freely choose the starting time of their eating window. If a participant need to make modifications to the start time of their eating window, he/she may do so only once during the TRE period, and the research team must be informed. After a washout period of at least 30 days, participants will undergo ii) Regular eating (REG), during which the participants must maintain their usual eating pattern (i.e., usual eating window), without making any dietary or lifestyle changes. Each condition will have a duration of 8 weeks. Randomization will be done using computer-generated random numbers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (range 18 - 60 yrs.) Men and women Performing as a healthcare worker Being a shift-worker for at least 6 months in the current schedule Working in rotating shiftwork, including at least one night shift Reporting no work-related performance difficulties

排除标准

  • Current and chronic neurological disorders
  • Pathologies related to abnormal adrenal activity
  • Liver or kidney disease
  • Uncontrolled hypertension, dyslipidemia, and thyroid disease
  • Insulin resistance and T2D
  • BMI ≥40 kg/m2
  • Use of medications known to alter body composition, such as insulin sensitizers, glucocorticoids, or anti-depressants
  • Autoimmune diseases with acute symptoms; recent surgery of any kind (in the last 3 months);
  • Acute, chronic inflammation (usCRP >10 mg/L)
  • Following any dietary restriction (special diet) in the previous three months
  • Having a short sleep (habitual sleep duration of less than 6h per day)
  • History of bariatric surgery
  • Depression (Beck Depression Inventory) or sleep disorders (Pittsburgh Sleep Questionnaire)
  • Night-eating syndrome (Night Eating Questionnaire)
  • Intense exercise level (>3 days/week of high-intensity exercise)
  • Having traveled across time zones (at any time during the last month) and planning travel during the study
  • Pregnant or intend to become pregnant, and
  • Lactating women

研究组 & 干预措施

Time-restricted eating

Experimental

Self-selected eating window of 10 hours per day without any other dietary modification (e.g., types of food or amount of energy consumed) for 8 weeks, with 14 hours fasting per day (mandatory fasting from 00:00h until 06:00h).

干预措施: Time-restricted eating (Behavioral)

Regular eating

No Intervention

Participants must maintain their usual eating pattern (i.e., usual eating window) for 8 weeks, but without any dietary or lifestyle changes

结局指标

主要结局

Change from Baseline in the mean fasting glycemia at 8 weeks

时间窗: From baseline to the end of treatment (at 8 weeks), in each study period (TRE and REG)

Fasting glycemia level (in mg/dL) will be measured from fasting blood samples and measured with the hexokinase method

次要结局

  • Change from baseline to end of treatment (8weeks) in 24-h glycemic control(From baseline to the end of treatment (at 8 weeks), in each study period (TRE and REG))
  • 24-hour motor activity level (counts/min)(From enrollment to the end of treatment (at 8 weeks), in each study period (TRE and REG))
  • Change from Baseline in the circadian clock-genes expression at 8 weeks(From baseline to the end of treatment (at 8 weeks), in each study period (TRE and REG))
  • Change from baseline in thiobarbituric acid reactive substances (TBARS) level at 8 weeks(From baseline to the end of treatment (8 weeks) in each study period (TRE and REG)])
  • Change from baseline in F-8 isoprostane level at 8 weeks(From baseline to the end of treatment (8 weeks) in each study period (TRE and REG))
  • Change from Baseline in Appetite-related feelings at 8 weeks(From baseline to the end of treatment (8 weeks) in each study period (TRE and REG))
  • Change from baseline in total-, reduced- and oxidized glutathione levels at 8 weeks(From baseline to the end of treatment (8 weeks) in each study period (TRE and REG))
  • Change from baseline in C-reactive protein levels at 8 weeks(From baseline to the end of treatment (8 weeks) in each study period (TRE and REG))
  • Change from baseline in pro-inflammatory cytokine levels at 8 weeks(From baseline to the end of treatment (8 weeks) in each study period (TRE and REG))

研究者

发起方
University of Chile
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rodrigo Chamorro

Principal Investigator

University of Chile

研究点 (1)

Loading locations...

相似试验